COVID-19
Showing NaN - NaN of 92
Acquiring Convalescent Specimens for COVID-19 Antibodies
Completed
- COVID-19
- +2 more
- Blood draw
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jul 18, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +4 more
-
Athens, Alabama
- +158 more
Jul 18, 2022
SARS-COV2 (COVID-19) Persistence After Convalescence
Recruiting
- COVID-19
- +2 more
-
New York, New YorkColumbia University Medical Center
Jul 19, 2022
COVID-19, COVID-19 Testing Trial in New York (Motivational interviewing (MI) counseling, Text messages (TMs) and quiz questions
Recruiting
- COVID-19
- COVID-19 Testing
- Motivational interviewing (MI) counseling
- +3 more
-
New York, New YorkNew York University Silver School of Social Work
Jul 15, 2022
COVID-19 Trial in New York (Nurse-Community-Family Partnership Intervention)
Recruiting
- COVID-19
- Nurse-Community-Family Partnership Intervention
-
New York, New YorkNew York University
Jul 13, 2022
COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein
Active, not recruiting
- COVID-19
- SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
- +10 more
-
Birmingham, Alabama
- +71 more
Jul 11, 2022
COVID-19 Vaccination and Breakthrough Infections Among Persons
Completed
- Immunocompromised
- +5 more
- BNT162b2 (Tozinameran)
-
New York, New YorkPfizer Inc.
Jul 1, 2022
Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)
Recruiting
- Lower Respiratory Tract Infection
- +3 more
- DAS181
- +3 more
-
Duarte, California
- +59 more
Jun 3, 2022
COVID-19 Trial in Worldwide (Liquid Alpha1-Proteinase Inhibitor (Human), Placebo, Standard Medical Treatment)
Terminated
- COVID-19
- Liquid Alpha1-Proteinase Inhibitor (Human)
- +2 more
-
Birmingham, Alabama
- +19 more
Apr 12, 2022
COVID-19, Acute Kidney Injury, Chronic Kidney Injury Trial in United States
Recruiting
- COVID-19
- +2 more
-
New Haven, Connecticut
- +4 more
Apr 13, 2022
Covid-19, Coronavirus Infection, Coronavirus Trial in New York (COVID-19 Serology, Health Care Worker Survey)
Recruiting
- Covid-19
- +2 more
- COVID-19 Serology
- Health Care Worker Survey
-
New York, New YorkNewYork-Presbyterian Hosptial/Columbia University Irving Medical
Apr 4, 2022
COVID-19, Coronavirus, Coronavirus Infection Trial in United States (Convalescent Plasma, Saline solution)
Active, not recruiting
- COVID-19
- +2 more
- Convalescent Plasma
- Saline solution
-
New Haven, Connecticut
- +8 more
Mar 30, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial in Worldwide (SNG001, Placebo)
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVID-19
- SNG001
- Placebo
-
Tucson, Arizona
- +111 more
Mar 2, 2022
COVID-19 Trial in New York (Cohorting)
Recruiting
- COVID-19
- Cohorting
-
New York, New York
- +1 more
Mar 7, 2022
Corona Virus Infection, COVID-19, SARS Trial in New York (Zofin, Placebo)
Active, not recruiting
- Corona Virus Infection
- +3 more
- Zofin
- Placebo
-
New York, New YorkGeorge C. Shapiro
Feb 2, 2022